Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 24;71(1):226-236.
doi: 10.1093/cid/ciz1082.

Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation

Thomas Lehrnbecher  1 , Brian T Fisher  2 , Bob Phillips  3   4 , Sarah Alexander  5 , Roland A Ammann  6 , Melissa Beauchemin  7 , Fabianne Carlesse  8 , Elio Castagnola  9 , Bonnie L Davis  10 , L Lee Dupuis  11   12 , Grace Egan  5 , Andreas H Groll  13 , Gabrielle M Haeusler  14   15 , Maria Santolaya  16 , William J Steinbach  17 , Marianne van de Wetering  18 , Joshua Wolf  19 , Sandra Cabral  20 , Paula D Robinson  20 , Lillian Sung  5   12
Affiliations

Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation

Thomas Lehrnbecher et al. Clin Infect Dis. .

Abstract

Background: Bacteremia and other invasive bacterial infections are common among children with cancer receiving intensive chemotherapy and in pediatric recipients of hematopoietic stem cell transplantation (HSCT). Systemic antibacterial prophylaxis is one approach that can be used to reduce the risk of these infections. Our purpose was to develop a clinical practice guideline (CPG) for systemic antibacterial prophylaxis administration in pediatric patients with cancer and those undergoing HSCT.

Methods: An international and multidisciplinary panel was convened with representation from pediatric hematology/oncology and HSCT, pediatric infectious diseases (including antibiotic stewardship), nursing, pharmacy, a patient advocate, and a CPG methodologist. The panel used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to generate recommendations based on the results of a systematic review of the literature.

Results: The systematic review identified 114 eligible randomized trials of antibiotic prophylaxis. The panel made a weak recommendation for systemic antibacterial prophylaxis for children receiving intensive chemotherapy for acute myeloid leukemia and relapsed acute lymphoblastic leukemia (ALL). Weak recommendations against the routine use of systemic antibacterial prophylaxis were made for children undergoing induction chemotherapy for ALL, autologous HSCT and allogeneic HSCT. A strong recommendation against its routine use was made for children whose therapy is not expected to result in prolonged severe neutropenia. If used, prophylaxis with levofloxacin was recommended during severe neutropenia.

Conclusions: We present a CPG for systemic antibacterial prophylaxis administration in pediatric cancer and HSCT patients. Future research should evaluate the long-term effectiveness and adverse effects of prophylaxis.

Keywords: bacterial infection; hematopoietic stem cell transplantation; pediatric oncology; practice guideline; prevention.

PubMed Disclaimer

Comment in

References

    1. Ammann RA, Laws HJ, Schrey D, et al. . Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors. Eur J Paediatr 2015; 174:675–86. - PubMed
    1. Leather HL, Wingard JR.. Bacterial infections. Thomas’ hematopoietic cell transplantation. 5th ed. Chichester, UK: John Wiley & Sons, Ltd, 2015.
    1. Sung L, Buxton A, Gamis A, Woods WG, Alonzo TA. Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children’s Oncology Group. J Pediatr Hematol Oncol 2012; 34:e30–5. - PMC - PubMed
    1. Alexander S, Nieder M, Zerr DM, Fisher BT, Dvorak CC, Sung L. Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn? Pediatr Blood Cancer 2012; 59:16–20. - PMC - PubMed
    1. Lehrnbecher T, Sung L. Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia. Expert Rev Hematol 2014; 7:819–30. - PubMed

Publication types